Citation sources

Updated weekly. Details via Crossref

Crossref	Scopus	Google Scholar
6	5	Search

2025	Phase 1 single-centre placebo- and etomidate-controlled study in healthy volunteers to assess safety, tolerability, clinical effects, and pharmacokinetics of intravenous methoxyethyl etomidate hydrochloride (ET-26) British Journal of Anaesthesia Qinqin Yin, Yang Yang, Jin Liu, Lize Li, Xiaoran Yang, Lei Diao, Yi Sun, Wensheng Zhang, Xiaoqian Deng
2025	The pharmacokinetics and Concentration-QTc analysis of a new etomidate analog ET-26-HCl: a phase I trial in healthy Chinese subjects Frontiers in Pharmacology Kun He, Wenyu Zhang, Xiangran Kong, Lize Li, Lei Diao, Qing Wen, Guohai Su, Xiaoran Yang, Hongyan Zhao
2022	E161111 is an ultra-short-acting etomidate analogue with stable haemodynamics that elicits only slight adrenocortical suppression in rats PeerJ Bin Wang, Deying Gong, Yi Kang, Jin Liu, Jun Yang, Wen-sheng Zhang
2021	Propofol differentially induces unconsciousness and respiratory depression through distinct interactions between GABA<sub>A</sub> receptor and GABAergic neuron in corresponding nuclei Acta Biochimica et Biophysica Sinica Junli Jiang, Yingfu Jiao, P o Gao, Wen Yin, Wei Zhou, Yunchun Zhang, Yanjun Liu, Daxiang Wen, Yuan Wang, Liang Zhou, Tian Yu, Weifeng Yu
2020	Metabolite identification, tissue distribution, excretion and preclinical pharmacokinetic studies of ET-26-HCl, a new analogue of etomidate Royal Society Open Science Lu Yu, Xu Chen, Wen Sheng Zhang, Liang Zheng, Wen Wen Xu, Ming Yu Xu, Xue Hua Jiang, Ling Wang
2020	New insights for screening etomidate analogues in the human H295R cell model Toxicology in Vitro Chaoyi Deng, Deying Gong, Jun Yang, Bowen Ke, Yi Kang, Jin Liu, Wensheng Zhang